ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation

Mise à jour : Il y a 4 ans
Référence : NCT00291759

Femme Homme

  • | Pays :
  • Austria
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to assess the difference in event-free survival between postmenopausal women with hormone receptor-positive early breast cancer who switched from tamoxifen to anastrozole and those who continued to receive tamoxifen.


Critère d'inclusion

  • Breast Cancer

Liens